Securities code: 300529 securities abbreviation: Jafron Biomedical Co.Ltd(300529) Announcement No.: 2022-006 bond Code: 123117 bond abbreviation: Jianfan convertible bond
Jafron Biomedical Co.Ltd(300529)
Announcement on the progress of the plan of controlling shareholders and actual controllers to increase their shares in the company
Mr. Dong Fan, the controlling shareholder and actual controller of the company, guarantees that the information disclosed to the company is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor.
Special tips:
1. Basic information of the share increase plan: Jafron Biomedical Co.Ltd(300529) (hereinafter referred to as “the company”) disclosed the announcement on the share increase plan of the controlling shareholder and actual controller of the company (Announcement No. 2021-122) on November 11, 2021. Mr. Dong Fan, the controlling shareholder and actual controller of the company, plans to adopt centralized bidding Increase the company’s shares by block trading or other means permitted by laws and regulations. The total amount of increased shares shall not be less than RMB 100 million and not more than RMB 200 million (including this number). There is no price range for this increase. The increase plan will be implemented at an appropriate time according to the fluctuation of the company’s stock price and the overall trend of the secondary market.
2. Implementation of the shareholding increase plan: from January 20, 2022 to January 21, 2022, Mr. Dong Fan increased 2089883 shares through centralized bidding trading through the trading system of the stock exchange, accounting for 0.26% of the total share capital of the company (excluding the total share capital after the number of shares in the company’s special repurchase account, the same below), and the cumulative amount of shareholding increase was 104.9792 million yuan. As of the date of this announcement, Mr. Dong Fan’s cumulative increase amount has reached the lower limit of his increase plan of RMB 100 million. The relevant information is hereby announced as follows:
1、 Basic information of increased holding subjects
1. Increased shareholding subject: Mr. Dong Fan, the controlling shareholder and actual controller of the company.
2. Before the implementation of this shareholding increase plan, Mr. Dong Fan held 350828772 shares of the company, accounting for 44.04% of the total share capital of the company.
3. Except for this share increase plan, Mr. Dong Fan did not disclose the share increase plan within 12 months before the disclosure date of the share increase plan.
4. Mr. Dong Fan did not reduce his shares in the company within 6 months before the disclosure of the increase plan.
2、 Main contents of share increase plan
1. Purpose of this share increase
Based on the firm confidence in the future development of the company and the recognition of long-term investment value, this shareholding increase plan is implemented to promote the sustainable, stable and healthy development of the company and enhance investor confidence.
2. Amount of shares increased this time
The total amount of increased holdings shall not be less than RMB 100 million and not more than RMB 200 million (both inclusive)
3. Price premise of this increase in shares
No price range is set for this increase, and the increase plan will be implemented at an appropriate time according to the fluctuation of the company’s stock price and the overall trend of the capital market.
4. Implementation period of this shareholding increase plan
Within 6 months from November 11, 2021 (except for the period during which the increase of shares is not allowed by laws, regulations and business rules of Shenzhen Stock Exchange). During the implementation of the share increase plan, if the trading of the company’s shares is suspended due to planning major events, the implementation of the share increase plan will be postponed after the resumption of trading.
5. Mode of this share increase
According to the regulations of China Securities Regulatory Commission and Shenzhen Stock Exchange, increase the company’s shares through centralized bidding, block trading or other ways permitted by laws and regulations.
6. Lock up arrangement for this share increase
Mr. Dong Fan promises not to reduce his shares in the company during the increase period and within six months after the completion of the increase plan. This increase will be carried out in strict accordance with the relevant laws, regulations and normative documents of China Securities Regulatory Commission and Shenzhen Stock Exchange, and will not carry out insider trading, trading of shares in sensitive periods, short-term trading, etc. 3、 Implementation of this shareholding increase plan
1. Progress of share increase
From January 20, 2022 to January 21, 2022, Mr. Dong Fan accumulatively increased 2089883 shares through centralized bidding trading through the trading system of the stock exchange, accounting for 0.26% of the total share capital of the company, and the accumulated increased amount was 104.9792 million yuan. The details are as follows:
Name of shareholder increase mode increase time increase number of shares (shares) increase proportion
Dong Fan centralized bidding 2022.1.20 1184700 0 0.15% centralized bidding 2022.1.21 905183 0.11%
Total 2089883 0.26%
2. Shareholding of Mr. Dong Fan before and after the implementation of this increase
Name of shareholders shareholding before the implementation of this increase shareholding after the completion of this increase
Proportion of shares (shares) in total share capital proportion of shares (shares) in total share capital
Dong Fan 350828772 44.04% 352918655 44.30%
Note: total share capital refers to the total share capital excluding the number of shares in the company’s special account for repurchase
3. Subsequent share increase plan
Mr. Dong Fan will continue to fulfill the relevant commitments of the share increase plan disclosed in the early stage and continue to increase his shares in the company. 4、 Other instructions
1. This increase complies with relevant laws, regulations, normative documents and business rules of Shenzhen Stock Exchange.
2. The implementation of this share increase will not lead to the company’s equity distribution not meeting the listing conditions, will not affect the company’s listing status, and will not lead to changes in the company’s controlling shareholders and actual controllers.
3. The company will continue to pay attention to the progress of this shareholding increase plan and timely perform the obligation of information disclosure in accordance with relevant regulations.
5、 Documents for future reference
1. Notification letter on the implementation progress of Jafron Biomedical Co.Ltd(300529) share increase plan issued by Mr. Dong Fan.
It is hereby announced.
Jafron Biomedical Co.Ltd(300529) board of directors January 24, 2022
